$CYAD Celyad Oncology Presents Preliminary Data from Phase 1 IMMUNICY-1 Trial of shRNA-based Allogeneic CAR T Candidate CYAD-211 in Relapsed/Refractory Multiple Myeloma at the European Hematology Associatio

on June 11, 2021 News and Tags: , , , with 0 comments
Time:
2:59 AM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more

$CYAD Transparency notification received from Victory Capital Management Inc. (Article 14 §1 of the Law of 2 May 2007)

on May 19, 2021 News and Tags: , , , with 0 comments
Time:
1:00 AM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more

$CYAD Transparency notification received from Victory Capital Management Inc. (Article 14 §1 of the Law of 2 May 2007)

on May 18, 2021 News and Tags: , , , with 0 comments
Time:
1:00 AM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more

$CYAD Celyad Oncology to Present Data from Phase 1 IMMUNICY-1 Trial of Non-Gene Edited Allogeneic CAR T Candidate CYAD-211 in Relapsed/Refractory Multiple Myeloma at the European Hematology Association Virt

on May 12, 2021 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more

$CYAD Celyad Oncology Announces First Quarter 2021 Financial Results and Recent Business Highlights

on May 6, 2021 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more

$CYAD Transparency Notification Received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

on May 5, 2021 News and Tags: , , , with 0 comments
Time:
1:00 AM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more

$CYAD Transparency Notification Received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

on May 4, 2021 News and Tags: , , , with 0 comments
Time:
1:00 AM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more

$CYAD Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

on May 4, 2021 News and Tags: , , , with 0 comments
Time:
1:00 AM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more

$CYAD Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

on May 3, 2021 News and Tags: , , , with 0 comments
Time:
1:00 AM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more

$CYAD Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

on April 30, 2021 News and Tags: , , , with 0 comments
Time:
1:00 AM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more

$CYAD Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

on April 29, 2021 News and Tags: , , , with 0 comments
Time:
1:00 AM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more

$CYAD Celyad Oncology Appoints Dr. Charles Morris as Chief Medical Officer

on April 19, 2021 News and Tags: , , , with 0 comments
Time:
1:00 AM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more

$CYAD Celyad Oncology Appoints Dr. Charles Morris as Chief Medical Officer

on April 18, 2021 News and Tags: , , , with 0 comments
Time:
1:00 AM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more

$CYAD Celyad Oncology Reports Full Year 2020 Financial Results and Recent Business Highlights

on March 24, 2021 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more

$CYAD Celyad Oncology to Announce Full Year 2020 Financial Results and Host Conference Call

on March 18, 2021 News and Tags: , , , with 0 comments
Time:
2:00 AM
Symbol:
CYAD
Source:
GlobeNewswire News Releases
Read more